LGALS3 and congestive heart failure: Galectin-3 was significantly elevated in CHF patients, correlated with the severity of LV dysfunction and NYHA class, and predicted all-cause mortality over 3 years; a multimarker panel improved prognostic value beyond NT-proBNP alone.